Sofwave Medical announced that its ultrasound skin tightening platform has surpassed one million treatments worldwide, with the millionth procedure performed in South Korea. The milestone underscores growing adoption of non-invasive skin tightening as an alternative to surgical facelift and competitive energy-device modalities.
Devices & Tech
Sofwave Hits One Million Treatments Milestone
Ultrasound skin tightening device reaches global adoption threshold.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
One million Sofwave treatments reflects sustained demand for non-invasive tightening.
Sofwave's rapid adoption reflects strong clinical outcomes, favorable safety profile, and expanding reimbursement in certain markets. For practice owners evaluating skin tightening devices, the volume milestone signals market validation and supply-chain stability. However, competitive intensity remains high: radiofrequency (InMode, Cutera), microfocused ultrasound (Ultherapy PRIME), and combination platforms (RF microneedling) continue to fragment the category. Practices should benchmark Sofwave's treatment economics, patient satisfaction, and revenue per treatment against alternative modalities before capital commitment.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.